掃碼下載
BTC $62,531.51 +2.13%
ETH $1,633.20 +2.90%
BNB $593.92 +2.19%
XRP $1.13 +4.42%
SOL $65.22 +2.81%
TRX $0.3286 +2.61%
DOGE $0.0852 +3.55%
ADA $0.1652 +3.88%
BCH $226.75 +1.32%
LINK $7.76 +4.11%
HYPE $59.40 -1.23%
AAVE $63.71 +2.18%
SUI $0.7579 +5.80%
XLM $0.2044 +0.94%
ZEC $399.53 +5.81%
BTC $62,531.51 +2.13%
ETH $1,633.20 +2.90%
BNB $593.92 +2.19%
XRP $1.13 +4.42%
SOL $65.22 +2.81%
TRX $0.3286 +2.61%
DOGE $0.0852 +3.55%
ADA $0.1652 +3.88%
BCH $226.75 +1.32%
LINK $7.76 +4.11%
HYPE $59.40 -1.23%
AAVE $63.71 +2.18%
SUI $0.7579 +5.80%
XLM $0.2044 +0.94%
ZEC $399.53 +5.81%

彭博社:Arthur Hayes 近期重金投資某人類壽命延長公司,過去 1 年定期接受幹細胞靜脈輸注治療

2025-08-21 09:43:07
收藏

ChainCatcher 消息,据彭博社報導,BitMEX 聯合創始人 Arthur Hayes 正將投資目光轉向人類壽命延長領域,其近期重金投資了一家在墨西哥和曼谷設有診所的幹細胞企業,並加入其董事會。

過去一年他定期乘機前往接受靜脈輸注治療,直言"希望儘可能健康地延長壽命"。儘管因品牌重塑暫未透露公司名稱,但他強調:這是未來趨勢------越來越多國家正放寬幹細胞使用法規。

app_icon
ChainCatcher 與創新者共建Web3世界